Drug:
Reaction: NEUTROPENIA
20250101 - 20251231
No. 301 - 400
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
301 | 25079095 |
GB |
46 | 1 |
Neutropenia, Myelosuppression, Osteonecrosis, Osteoarthritis, Fear of injection, Arthralgia, |
||||
CABOTEGRAVIR SODIUM, |
||||
302 | 25079465 |
TN |
70 | 2 |
Breast cancer metastatic, Malignant neoplasm progression, Neutropenia, |
||||
PALBOCICLIB, |
||||
303 | 25079473 |
FR |
54 | 2 |
Neutropenia, |
||||
PANTOPRAZOLE, AMOXICILLIN AND CLAVULANATE POTASSIUM, METRONIDAZOLE, METRONIDAZOLE TOPICAL, CEFTRIAXONE, CEFTRIAXONE SODIUM, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
304 | 25079772 |
FR |
69 | 2 |
Neutropenia, Malignant neoplasm progression, Diarrhoea, Visual impairment, Oedema, Hypertension, Oedema peripheral, |
||||
SELPERCATINIB, GEMCITABINE HYDROCHLORIDE, PEMETREXED, PEMETREXED DISODIUM, CABOZANTINIB, OSIMERTINIB, OSIMERTINIB, TRAMETINIB, CARBOPLATIN, |
||||
305 | 25079979 |
KR |
55 | 1 |
Neutropenia, |
||||
METHOTREXATE SODIUM, VINCRISTINE SULFATE, RITUXIMAB, |
||||
306 | 25071578 |
FR |
10 | 1 |
Hypogammaglobulinaemia, Neutropenia, Off label use, Vomiting, Off label use, Urticaria, Blood immunoglobulin G decreased, Product use in unapproved indication, |
||||
DARATUMUMAB, OBINUTUZUMAB, METHYLPREDNISOLONE, PREDNISONE, PREDNISONE, PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, CYCLOSPORINE, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
307 | 25071613 |
FR |
||
Haematological malignancy, Cataract, Neutropenia, Pneumonia, Neoplasm, Peripheral sensory neuropathy, Diarrhoea, Upper respiratory tract infection, Infection, |
||||
LENALIDOMIDE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
308 | 25071875 |
US |
||
Hyperkalaemia, Neutropenia, Lymphopenia, Blood alkaline phosphatase increased, Fatigue, Alanine aminotransferase increased, |
||||
LONCASTUXIMAB TESIRINE, RITUXIMAB, |
||||
309 | 25071922 |
US |
82 | 1 |
Leukopenia, Neutropenia, Thrombocytopenia, Skin lesion, |
||||
LENALIDOMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ROSUVASTATIN, FUROSEMIDE, GABAPENTIN, NITROGLYCERIN, |
||||
310 | 25071991 |
US |
1 | |
Neutropenia, |
||||
GLOFITAMAB, |
||||
311 | 25071992 |
US |
51 | 1 |
Neutropenia, Cough, |
||||
GLOFITAMAB, POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, DOXORUBICIN, |
||||
312 | 25072102 |
JP |
72 | 1 |
Neutropenia, Toxic skin eruption, |
||||
NIVOLUMAB, PACLITAXEL, CARBOPLATIN, |
||||
313 | 25072204 |
IT |
73 | 2 |
Neutropenia, Vomiting, Drug ineffective, Gastrointestinal toxicity, Nausea, Paraesthesia, Diarrhoea, Abdominal pain, |
||||
RAMIPRIL, PACLITAXEL, SACITUZUMAB GOVITECAN, CAPECITABINE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, VINORELBINE, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ROSUVASTATIN, PANTOPRAZOLE, |
||||
314 | 25072209 |
GB |
2 | |
Neutropenia, Product dose omission issue, |
||||
OFATUMUMAB, |
||||
315 | 25072581 |
SE |
57 | 1 |
C-reactive protein increased, Pyrexia, Neutropenia, Thrombocytopenia, |
||||
SEMAGLUTIDE, TRAMETINIB, DABRAFENIB, |
||||
316 | 25072787 |
PL |
71 | 1 |
Neutropenia, Asthenia, |
||||
CISPLATIN, VINORELBINE, CISPLATIN, |
||||
317 | 25072838 |
FR |
9 | 1 |
Hypogammaglobulinaemia, Neutropenia, Urticaria, Product use issue, Off label use, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISONE, PREDNISONE, PREDNISONE, DARATUMUMAB, CYCLOSPORINE, OBINUTUZUMAB, METHYLPREDNISOLONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
318 | 25072841 |
US |
1 | |
Pneumocystis jirovecii pneumonia, Neutropenia, |
||||
VENETOCLAX, OBINUTUZUMAB, |
||||
319 | 25072959 |
US |
48 | 1 |
Product dose omission issue, Neutropenia, |
||||
CLOZAPINE, |
||||
320 | 25073246 |
JP |
9 | 1 |
Neutropenia, |
||||
ATEZOLIZUMAB, ETOPOSIDE, CARBOPLATIN, |
||||
321 | 25073295 |
IT |
66 | 1 |
Neutropenia, Haemoglobin decreased, Off label use, |
||||
TRASTUZUMAB, |
||||
322 | 25073370 |
JP |
1 | |
Hypomagnesaemia, Neutropenia, Renal disorder, Arthralgia, Aspartate aminotransferase increased, Alanine aminotransferase increased, Anaemia, Condition aggravated, Fatigue, Tremor, Dizziness, |
||||
CARBOPLATIN, PACLITAXEL, |
||||
323 | 25074183 |
81 | 2 | |
Fatigue, Dizziness, Neutropenia, |
||||
DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, |
||||
324 | 25074317 |
FR |
64 | 2 |
Neutropenia, Myelodysplastic syndrome, Anaemia, |
||||
METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, |
||||
325 | 25074526 |
PL |
72 | 1 |
Neutropenia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, FLUOROURACIL, OXALIPLATIN, |
||||
326 | 25074528 |
PL |
72 | 1 |
Neutropenia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, FLUOROURACIL, OXALIPLATIN, |
||||
327 | 25074538 |
PL |
72 | 1 |
Neutropenia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, OXALIPLATIN, FLUOROURACIL, |
||||
328 | 25074549 |
PL |
72 | 1 |
Neutropenia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, FLUOROURACIL, OXALIPLATIN, |
||||
329 | 25074610 |
FR |
||
Haematological malignancy, Neutropenia, Cataract, Pneumonia, Neoplasm, Diarrhoea, Peripheral sensory neuropathy, Upper respiratory tract infection, Infection, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BORTEZOMIB, LENALIDOMIDE, |
||||
330 | 25074627 |
ES |
68 | 1 |
Hyperamylasaemia, Hypertransaminasaemia, Neutropenia, |
||||
GLOFITAMAB, OXALIPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
331 | 25074861 |
JP |
7 | 2 |
Neutropenia, Leukopenia, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, NECITUMUMAB, |
||||
332 | 25074881 |
CA |
6 | 1 |
Back pain, Headache, Neutropenia, Pyrexia, Thrombocytopenia, |
||||
CYTARABINE, HYDROCORTISONE SODIUM SUCCINATE, METHOTREXATE SODIUM, LANSOPRAZOLE, MERCAPTOPURINE, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
333 | 25074910 |
AR |
37 | 1 |
Neutropenia, Neutrophil count increased, |
||||
CLOZAPINE, |
||||
334 | 25075007 |
US |
63 | 1 |
Neutropenia, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CYCLOSPORINE, CYCLOSPORINE, |
||||
335 | 25075012 |
KR |
2 | |
Neutropenia, Septic shock, |
||||
DENOSUMAB, |
||||
336 | 25075022 |
FI |
75 | 2 |
Neutropenia, |
||||
CEFTAZIDIME, MEROPENEM, |
||||
337 | 25075243 |
CN |
||
Neutropenia, Leukopenia, Hypokalaemia, Cervix carcinoma, Febrile neutropenia, Thrombocytopenia, Injection site pain, Gastrointestinal disorder, Transaminases abnormal, Anaemia, Bone pain, Arthralgia, |
||||
FILGRASTIM, PEGFILGRASTIM, CISPLATIN, CARBOPLATIN, |
||||
338 | 25075281 |
FR |
57 | 1 |
Neutropenia, |
||||
MIRTAZAPINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, |
||||
339 | 25075565 |
AL |
73 | 1 |
Neutropenia, Lung disorder, Drug intolerance, |
||||
DAROLUTAMIDE, GOSERELIN, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
340 | 25075805 |
BA |
64 | 2 |
Bone marrow failure, Neutropenia, Inflammatory marker increased, Anaemia, Thrombocytopenia, Haemorrhage subcutaneous, |
||||
METHYLPREDNISOLONE, RITUXIMAB, ETOPOSIDE, CYTARABINE, CISPLATIN, |
||||
341 | 25076058 |
RU |
24 | 2 |
Leukopenia, Neutropenia, Stomatitis, Mucosal dryness, Dermatitis acneiform, Amenorrhoea, Alopecia, Metastases to lung, Paranasal sinus inflammation, Lymphoid tissue hyperplasia, Haemangioma, Enostosis, Ovarian enlargement, Ovarian cyst, Maternal exposure during pregnancy, |
||||
TRASTUZUMAB, PERTUZUMAB, ADO-TRASTUZUMAB EMTANSINE, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
342 | 25076220 |
US |
67 | 1 |
Death, Pulmonary oedema, Respiratory failure, Renal failure, Atrial fibrillation, Neutropenia, Hypersplenism, Diarrhoea, Nausea, Cough, Dyspnoea, Oedema peripheral, Confusional state, Off label use, |
||||
ISAVUCONAZONIUM SULFATE, IVOSIDENIB, |
||||
343 | 25076261 |
JP |
51 | 2 |
Immune-mediated adrenal insufficiency, Immune-mediated hypothyroidism, Neutropenia, Tachycardia, Malaise, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CARBOPLATIN, PACLITAXEL, |
||||
344 | 25076266 |
PL |
40 | 2 |
Neutropenia, Neutrophil count decreased, Upper respiratory tract infection, Rhinorrhoea, Parainfluenzae virus infection, Viral infection, Asthenia, |
||||
ZOLEDRONIC ACID, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LEVOTHYROXINE SODIUM, |
||||
345 | 25076273 |
FR |
75 | 1 |
Lymphopenia, Benign prostatic hyperplasia, Thrombocytopenia, Neutropenia, Pneumonia, Escherichia bacteraemia, Clostridium colitis, Anaemia, Ear pain, Depression, Epistaxis, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, CARFILZOMIB, CARFILZOMIB, CARFILZOMIB, CARFILZOMIB, CARFILZOMIB, LANSOPRAZOLE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, FAMOTIDINE, CYANOCOBALAMIN, CYANOCOBALAMIN, FILGRASTIM, APIXABAN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, OXACILLIN SODIUM, OXACILLIN SODIUM, FOLIC ACID, |
||||
346 | 25076595 |
CA |
76 | 2 |
Anaemia, Myelosuppression, Neutropenia, Pancytopenia, Thrombocytopenia, |
||||
CEDAZURIDINE AND DECITABINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LACTULOSE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
347 | 25076661 |
IT |
54 | 2 |
Cholangitis acute, Neutropenia, |
||||
PEMBROLIZUMAB, LEVOTHYROXINE, PACLITAXEL, CARBOPLATIN, |
||||
348 | 25076823 |
IT |
86 | 1 |
Febrile neutropenia, Neutropenia, |
||||
AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, VENETOCLAX, VENETOCLAX, |
||||
349 | 25078180 |
64 | 1 | |
Infusion related reaction, Cytopenia, Anaemia, Neutropenia, Thrombocytopenia, Lymphopenia, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
350 | 25066404 |
IT |
84 | 1 |
Duodenitis, Pneumonia, Neutropenia, Brain injury, Gingival bleeding, Gingival bleeding, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, AZACITIDINE, AZACITIDINE FOR, ALLOPURINOL, FILGRASTIM, FILGRASTIM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
351 | 25066594 |
SG |
37 | |
Neutropenia, Deafness, Off label use, |
||||
VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, |
||||
352 | 25066988 |
JP |
2 | |
Neutropenia, Platelet count decreased, Metastases to meninges, |
||||
SACITUZUMAB GOVITECAN, |
||||
353 | 25067032 |
FR |
76 | 1 |
Leukopenia, Neutropenia, Fatigue, Cough, Toxicity to various agents, |
||||
ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, |
||||
354 | 25067119 |
IT |
57 | 1 |
Neuropathy peripheral, Neutropenia, |
||||
POLATUZUMAB VEDOTIN, RITUXIMAB, DOXORUBICIN, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
355 | 25067499 |
US |
70 | 2 |
Diarrhoea, Nausea, Neutropenia, Chills, Body temperature increased, |
||||
CAPECITABINE, |
||||
356 | 25067880 |
US |
65 | 2 |
Neutrophil count decreased, Neutropenia, |
||||
LENALIDOMIDE, |
||||
357 | 25067934 |
FI |
17 | 1 |
Neutropenia, White blood cell count decreased, Pyrexia, Off label use, |
||||
CLOZAPINE, CLOZAPINE, |
||||
358 | 25067938 |
IT |
81 | 2 |
Pyrexia, Neutropenia, C-reactive protein increased, Headache, Neck pain, |
||||
LENALIDOMIDE, LENALIDOMIDE, DARATUMUMAB, DARATUMUMAB, |
||||
359 | 25067943 |
GB |
1 | |
Neutropenia, Leukopenia, Eosinophil count decreased, Platelet count increased, Off label use, |
||||
CLOZAPINE, CLOZAPINE, |
||||
360 | 25068011 |
FI |
1 | |
Neutropenia, White blood cell count decreased, Off label use, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, RISPERIDONE, LITHIUM CARBONATE, |
||||
361 | 25068071 |
PL |
71 | 1 |
Neutropenia, Thrombocytopenia, |
||||
FLUOROURACIL, OXALIPLATIN, FLUOROURACIL, |
||||
362 | 25068853 |
US |
1 | |
Neutropenia, Fatigue, |
||||
ASCIMINIB, |
||||
363 | 25069239 |
US |
19 | 1 |
Hospitalisation, Neutropenia, |
||||
CLOZAPINE, |
||||
364 | 25069314 |
PL |
72 | 1 |
Neutropenia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
365 | 25069661 |
US |
2 | |
Lung neoplasm malignant, Neutropenia, |
||||
CLOZAPINE, |
||||
366 | 25069964 |
AR |
44 | 2 |
Neutropenia, Monocyte count increased, |
||||
CLOZAPINE, |
||||
367 | 25070025 |
US |
72 | 2 |
Neutropenia, |
||||
RIBOCICLIB, RIBOCICLIB, |
||||
368 | 25070972 |
CA |
38 | 2 |
Neutropenia, Autoimmune disorder, Therapy interrupted, Leukopenia, |
||||
CLOZAPINE, CLOZAPINE, |
||||
369 | 25071050 |
KR |
53 | 2 |
Neutropenia, Platelet count decreased, |
||||
PEMBROLIZUMAB, CARBOPLATIN, PACLITAXEL, |
||||
370 | 25071065 |
TR |
||
Renal impairment, Osteonecrosis of jaw, Leukopenia, Neutropenia, Thrombocytopenia, Musculoskeletal disorder, Hypocalcaemia, Nausea, Fatigue, Back pain, Arthralgia, Diarrhoea, Dyspnoea, Anaemia, |
||||
DENOSUMAB, ZOLEDRONIC ACID, |
||||
371 | 25071209 |
JP |
2 | |
Triple negative breast cancer, Neutropenia, |
||||
SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, |
||||
372 | 25071259 |
FR |
70 | 1 |
Neutropenia, Pruritus, Rash macular, Leukopenia, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
373 | 25061408 |
NO |
||
Neutropenia, Thrombocytopenia, Anaemia, Neuropathy peripheral, Arrhythmia, Infection, Bone pain, Diarrhoea, Arthritis, Intentional product use issue, |
||||
BORTEZOMIB FOR INJECTION, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ISATUXIMAB, LENALIDOMIDE, |
||||
374 | 25061554 |
CN |
2 | |
Febrile neutropenia, Neutropenia, Bone pain, Arthralgia, Myalgia, |
||||
FILGRASTIM, FILGRASTIM, FILGRASTIM, PEGFILGRASTIM, PEGFILGRASTIM, PEGFILGRASTIM, TRASTUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, PERTUZUMAB, |
||||
375 | 25061767 |
IT |
47 | 2 |
Neutropenia, |
||||
EXEMESTANE, TRIPTORELIN, ABEMACICLIB, ABEMACICLIB, ERGOCALCIFEROL, |
||||
376 | 25062143 |
IT |
54 | 2 |
Multiple organ dysfunction syndrome, Decreased appetite, Diarrhoea, Asthenia, Neutropenia, Thrombocytopenia, Leukopenia, |
||||
BEVACIZUMAB, CARBOPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DEXAMETHASONE SODIUM PHOSPHATE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, FILGRASTIM, |
||||
377 | 25062642 |
IT |
52 | 1 |
Neutropenia, Off label use, |
||||
BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, |
||||
378 | 25062773 |
US |
||
Lymphopenia, Neutropenia, Thrombocytopenia, Anaemia, Plasma cell myeloma refractory, |
||||
CARFILZOMIB, |
||||
379 | 25062957 |
JP |
42 | 2 |
Dizziness, Muscular weakness, Toxicity to various agents, Drug interaction, Neutropenia, |
||||
CAPECITABINE, PHENYTOIN, OXALIPLATIN, |
||||
380 | 25063275 |
JP |
2 | |
Gastrointestinal necrosis, Ileus, Septic shock, Post procedural haemorrhage, Intestinal ischaemia, Thrombosis mesenteric vessel, Biliary ischaemia, Neutropenia, White blood cell count decreased, Platelet count decreased, |
||||
SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, |
||||
381 | 25063286 |
59 | 1 | |
Nausea, Vomiting, Abdominal pain, Hypophagia, Dizziness postural, Colitis, Proctitis, Hyponatraemia, Hypokalaemia, Neutropenia, Toxicity to various agents, Diarrhoea, Palmar-plantar erythrodysaesthesia syndrome, Mucosal inflammation, Gastrooesophageal reflux disease, Decreased appetite, Asthenia, Erythema, Sensitive skin, Stomatitis, Cheilitis, |
||||
CAPECITABINE, |
||||
382 | 25063338 |
BE |
2 | |
Neutropenia, |
||||
OFATUMUMAB, |
||||
383 | 25063492 |
JP |
49 | 1 |
Pneumonia, Cytokine release syndrome, Neutropenia, Immunodeficiency, Plasma cell myeloma, Cytomegalovirus infection, |
||||
ELRANATAMAB-BCMM, |
||||
384 | 25063887 |
DE |
50 | 1 |
Malignant neoplasm progression, Autoimmune thyroiditis, Hypokalaemia, Pneumonia staphylococcal, Neutropenia, Vascular device infection, Mucosal inflammation, Fatigue, Taste disorder, Tumour pain, |
||||
CARBOPLATIN, NIVOLUMAB, IPILIMUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GRANISETRON, GRANISETRON HYDROCHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, APREPITANT, CIPROFLOXACIN HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FILGRASTIM, |
||||
385 | 25063898 |
EG |
57 | 2 |
Neutropenia, |
||||
PANITUMUMAB, FLUOROURACIL, MESNA, MESNA INJECTION, |
||||
386 | 25063942 |
RO |
34 | 2 |
Hepatic cytolysis, Neutropenia, |
||||
387 | 25063970 |
VN |
54 | 2 |
Neutropenia, Dermatitis, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, DOCETAXEL, DOCETAXEL ANHYDROUS, RIBOCICLIB, RIBOCICLIB, GOSERELIN, |
||||
388 | 25064025 |
IT |
||
Neutropenia, Thrombocytopenia, Anaemia, Febrile neutropenia, Lymphopenia, Pneumonia, Second primary malignancy, Infection, Upper respiratory tract infection, Diarrhoea, Peripheral sensory neuropathy, Constipation, Epigastric discomfort, Dysgeusia, Pyrexia, Arthralgia, Asthenia, Cough, Fatigue, Rash, Back pain, Oedema peripheral, Nausea, Tendonitis, COVID-19, Herpes zoster, Infusion related reaction, |
||||
DARATUMUMAB, ACYCLOVIR, |
||||
389 | 25064093 |
PL |
72 | 1 |
Neutropenia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
390 | 25064094 |
PL |
71 | 1 |
Neutropenia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
391 | 25064104 |
PL |
71 | 1 |
Neutropenia, Hypokalaemia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
392 | 25064105 |
PL |
72 | 1 |
Neutropenia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
393 | 25064250 |
FR |
2 | |
Dermatitis exfoliative generalised, Neutropenia, Anaemia, White blood cell count decreased, |
||||
RIBOCICLIB, |
||||
394 | 25064265 |
MX |
61 | 2 |
Neutropenia, Neuropathy peripheral, Neutropenia, Anaemia, Diarrhoea, Neuropathy peripheral, Diarrhoea, Product use in unapproved indication, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, CARBOPLATIN, PACLITAXEL, |
||||
395 | 25064360 |
DE |
73 | 2 |
Neutropenia, Neutropenia, Neutropenia, Neutropenia, Neutropenia, Neutropenia, Neutropenia, Thrombocytopenia, Joint stiffness, Pulpitis dental, Dyspepsia, Abdominal pain, Dyspepsia, Back pain, Back pain, Fatigue, Diarrhoea, Aspartate aminotransferase increased, Alanine aminotransferase increased, |
||||
FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, |
||||
396 | 25064372 |
FR |
1 | |
Neutropenia, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, LENALIDOMIDE, DARATUMUMAB, |
||||
397 | 25064654 |
RO |
62 | 2 |
Neutropenia, Hepatic cytolysis, |
||||
RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, DENOSUMAB, |
||||
398 | 25064695 |
GB |
||
Neutropenia, Myelosuppression, Osteonecrosis, Osteoarthritis, Fear of injection, Arthralgia, |
||||
CABOTEGRAVIR SODIUM, CABOTEGRAVIR SODIUM, CABOTEGRAVIR SODIUM, |
||||
399 | 25064874 |
VN |
54 | 2 |
Dermatitis, Neutropenia, |
||||
RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, GOSERELIN, |
||||
400 | 25065068 |
TW |
||
Adverse event, Anaemia, Neutropenia, Febrile neutropenia, Thrombocytopenia, Hypokalaemia, Breast cancer metastatic, Hepatic function abnormal, Therapy partial responder, Blood creatinine increased, Hypomagnesaemia, Hyponatraemia, Weight decreased, Mucosal inflammation, |
||||
BEVACIZUMAB, BEVACIZUMAB, VINORELBINE, VINORELBINE, PLATINUM, PLATINUM, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28